Informing Public Health Decisions with Data and Science: Sue Desmond-Hellmann, M.D., Council of Advisors on Science and Technology

episode

The Real Chemistry Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

MIDWEEK RUB | Should Lachie Neale Get Off? Full Grand Final Preview + Brownlow Wrap 38 min · 23 Sep 2026 · Triple M Rocks Footy AFL

NPR News: 09-22-2026 9PM EDT 4 min · 23 Sep 2026 · NPR News Now

9PM ET 09/22/2026 Newscast 3 min · 23 Sep 2026 · Fox News Hourly Update

Stories from our Elders: My passionate friendship with a rebel poet 51 min · 23 Sep 2026 · Conversations

The forgotten nutrient every midlife woman needs – with Dr Craig Rose 41 min · 23 Sep 2026 · Age Better with Liz Earle

Bringing Kashmir’s lakes back to life 25 min · 23 Sep 2026 · The Documentary Podcast

Report any issue

Source

Recorded07 Sep 2023

Publisherfeeds.megaphone.fm

Handlerec:14494397

Show notes

In this episode, Dr. Sue Desmond-Hellmann, Member of President Biden’s Council of Advisors on Science and Technology and former CEO of the Bill & Melinda Gates Foundation, Mike Huckman, Global Practice Leader of Executive Communications at Real Chemistry, and Jim Weiss, Founder and Chairman at Real Chemistry, discuss the importance of vaccination, the evolution of cancer treatments and the challenges of clinical trials. They also highlight the need for diverse representation in clinical trials, the implications of the Inflation Reduction Act on the pharmaceutical industry and the influence of science in public health and policymaking.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in